Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

bausch & lomb-iom spa - prednisolone/atropina solfato/fenilefrina - collirio - "collirio, polvere e solvente per sospensione" 1 flacone polvere + 1 flacone di solvente da 4,2 ml

Unione Europea - italiano - EMA (European Medicines Agency)

janssen-cilag international n.v. - abiraterone acetato - neoplasie prostatiche - terapia endocrina - zytiga è indicato con prednisone o prednisolone per:il trattamento delle metastasi da cancro alla prostata resistente alla castrazione in uomini adulti che sono asintomatici o lievemente sintomatici dopo il fallimento della terapia di deprivazione androgenica nei quali la chemioterapia non è ancora clinicamente indicatedthe trattamento delle metastasi da cancro alla prostata resistente alla castrazione in uomini adulti, la cui malattia è progredita o dopo una chemioterapia a base di docetaxel regime.

Unione Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - abiraterone acetato - neoplasie prostatiche - terapia endocrina - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Unione Europea - italiano - EMA (European Medicines Agency)

mylan ireland limited - abiraterone acetato - neoplasie prostatiche - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Unione Europea - italiano - EMA (European Medicines Agency)

krka, d.d., novo mesto - abiraterone acetato - neoplasie prostatiche - terapia endocrina - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Italia - italiano - Ministero della Salute

alpha-vet veterinary ltd - ketoconazolo, prednisolone, gentamicina solfato, marbofloxacina - ketoconazolo - 4.08 mg; prednisolone - 1.85 mg; gentamicina solfato - 2.04 mg; marbofloxacina - 2.04 mg - antiinfectives, combinations

Italia - italiano - Ministero della Salute

alpha-vet veterinary ltd - ketoconazolo, prednisolone, marboflossacina - ketoconazolo - 2.04 mg; prednisolone - 0.93 mg; marboflossacina - 1.03 mg/ml, marboflossacina - 1.03 mg/ml; prednisolone - 0.93 mg; ketoconazolo - 2.04 mg - corticosteroids, other combinations

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

labatec pharma sa - methylprednisolonum - polvere per soluzione iniettabile - preparazione cryodesiccata: methylprednisolonum 40 mg ut methylprednisoloni-21 succinas natricus, lactosum monohydricum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas pro vitro. - la terapia con glucocorticoidi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

labatec pharma sa - methylprednisolonum - polvere per soluzione iniettabile - preparazione cryodesiccata: methylprednisolonum 125 mg ut methylprednisoloni-21 succinas natricus, natrii dihydrogenophosphas dihydricus, dinatrii phosphas pro vitro. - la terapia con glucocorticoidi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

labatec pharma sa - methylprednisolonum - polvere per soluzione iniettabile - preparazione cryodesiccata: methylprednisolonum 250 mg ut methylprednisoloni-21 succinas natricus, natrii dihydrogenophosphas dihydricus, dinatrii phosphas pro vitro. - la terapia con glucocorticoidi - synthetika